| Detected | Trial | Change |
|---|---|---|
| 2026-06-09 | NCT06962800 A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults… |
Trial sites expanded: 97 -> 100 locations |
| 2026-06-09 | NCT07219043 A Study to Learn About the Effects of Felzartamab Infusions in Adults With Kidney… |
Trial sites expanded: 26 -> 32 locations |
| 2026-06-06 | NCT06685757 A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-06-06 | NCT06685757 A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults… |
Enrollment increased: 120 -> 132 participants |
| 2026-06-06 | NCT06685757 A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults… |
Trial sites reduced: 59 -> 56 locations |
| 2026-06-05 | NCT07515014 A Study of E6742 in Participants With Systemic Lupus Erythematosus |
Trial sites expanded: 17 -> 22 locations |
| 2026-06-03 | NCT06953583 A Study to Learn More About the Effects and Long-Term Safety of Omaveloxolone (BIIB141)… |
Primary endpoint(s) modified |
| 2026-06-03 | NCT06953583 A Study to Learn More About the Effects and Long-Term Safety of Omaveloxolone (BIIB141)… |
Trial arms changed: 3 -> 4 |
| 2026-05-28 | NCT06935357 A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin… |
Trial sites expanded: 235 -> 239 locations |
| 2026-05-23 | NCT06188559 A Study of BB-1701 in Previously Treated Participants With Human Epidermal Growth Factor… |
Trial completed |
| 2026-05-23 | NCT06188559 A Study of BB-1701 in Previously Treated Participants With Human Epidermal Growth Factor… |
Enrollment reduced: 135 -> 56 participants |
| 2026-05-23 | NCT06188559 A Study of BB-1701 in Previously Treated Participants With Human Epidermal Growth Factor… |
date change Primary completion moved earlier: 2027-03-31 -> 2026-03-18 |
| 2026-05-23 | NCT06188559 A Study of BB-1701 in Previously Treated Participants With Human Epidermal Growth Factor… |
date change Completion moved earlier: 2027-03-31 -> 2026-03-18 |
| 2026-05-15 | NCT07297199 A Study to Learn How the Body Processes BIIB141 (Omaveloxolone) When Taken as a Capsule… |
Trial completed |
| 2026-05-15 | NCT07493265 A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy |
Recruitment opened |
| 2026-05-15 | NCT07493265 A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy |
Trial sites expanded: 0 -> 57 locations |
| 2026-05-14 | NCT05925049 A Study Utilising Data From European Union (EU) National Multiple Sclerosis (MS)… |
date change Primary completion pushed: 2026-04-30 -> 2026-10-31 |
| 2026-05-14 | NCT05925049 A Study Utilising Data From European Union (EU) National Multiple Sclerosis (MS)… |
date change Completion pushed: 2026-04-30 -> 2026-10-31 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07223723 | A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Chinese… | Amyotrophic Lateral Sclerosis | Recruiting |
| NCT06964113 | A Study of Filgotinib 200 mg in Korean Participants With Moderately to Severely Active… | Ulcerative Colitis | Recruiting |
| Phase 3 | |||
| NCT07444476 | A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety in… | Spinal Muscular Atrophy | Recruiting |
| NCT06953583 | A Study to Learn More About the Effects and Long-Term Safety of Omaveloxolone (BIIB141)… | Friedreich Ataxia | Recruiting |
| NCT06962800 | A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults… | Primary Membranous Nephropathy | Recruiting |
| NCT07221669 | A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When… | Muscular Atrophy, Spinal | Recruiting |
| NCT06935357 | A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin… | Immunoglobulin A Nephropathy (IgAN) | Recruiting |
| NCT04961567 | A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They… | Lupus Erythematosus, Systemic | Active, Not Recruiting |
| NCT04895241 | A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They… | Lupus Erythematosus, Systemic | Active, Not Recruiting |
| NCT04729907 | A Study to Learn About the Long-Term Safety of Higher Doses of Nusinersen (BIIB058) Given… | Muscular Atrophy, Spinal | Active, Not Recruiting |
| NCT02811861 | Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of… | Renal Cell Carcinoma | Active, Not Recruiting |
| NCT07483632 | A Study to Learn About the Safety of Diroximel Fumarate (DRF) and Dimethyl Fumarate (DMF)… | Relapsing Forms of Multiple Sclerosis | Not Yet Recruiting |
| NCT04856982 | A Study of BIIB067 (Tofersen) Initiated in Clinically Presymptomatic Adults With a… | Amyotrophic Lateral Sclerosis Associated With a SOD1 Gene Mutation | Active, Not Recruiting |
| NCT03887455 | A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early… | Early Alzheimer's Disease | Active, Not Recruiting |
| NCT07444489 | A Study to Learn More About the Long-Term Safety and Effects of Felzartamab Infusions in… | Antibody-mediated Rejection | Enrolling by Invitation |
| NCT06044337 | A Long-Term Extension Study to Learn More About the Safety of Litifilimab (BIIB059)… | Subacute Cutaneous Lupus Erythematosus | Enrolling by Invitation |
| NCT05067790 | A Study to Learn About the Effect of Higher Doses of Nusinersen (BIIB058) Given as… | Spinal Muscular Atrophy | Active, Not Recruiting |
| NCT04468659 | AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in… | Preclinical Alzheimer's Disease | Active, Not Recruiting |
| NCT06685757 | A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults… | Antibody-mediated Rejection | Active, Not Recruiting |
| NCT07444450 | A Study to Learn About the Safety and Effects of Salanersen (BIIB115) When Given to… | Muscular Atrophy, Spinal | Not Yet Recruiting |
| NCT05352919 | An Extension Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059)… | Systemic Lupus Erythematosus (SLE) | Enrolling by Invitation |
| Phase 2/3 | |||
| NCT05531565 | A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of… | Subacute Cutaneous Lupus Erythematosus | Recruiting |
| Phase 2 | |||
| NCT07493265 | A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy | Narcolepsy | Recruiting |
| NCT07515014 | A Study of E6742 in Participants With Systemic Lupus Erythematosus | Systemic Lupus Erythematosus | Recruiting |
| NCT07219043 | A Study to Learn About the Effects of Felzartamab Infusions in Adults With Kidney… | Microvascular Inflammation | Recruiting |